From Flow to Pharmaceuticals: Single-Cell Mechanobiology and Drug Efficacy
Arteriosclerosis, Thrombosis, and Vascular Biology · 2023
DOI: 10.1161/atvbaha.123.320117 ↗Kurz gefasst
Editorial in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2023. Verfasst von Joshua D Hutcheson. Beteiligte Einrichtung: Department of Biomedical Engineering and Biomolecular Sciences Institute, Florida International University, Miami. Hauptthemen laut MEDLINE: Endothelial Cells, Mechanotransduction, Cellular. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering and Biomolecular Sciences Institute, Florida International University, Miami.
ORCID-Profile: Joshua D Hutcheson
Zitieren
APA
Hutcheson, J. D. (2023). From Flow to Pharmaceuticals: Single-Cell Mechanobiology and Drug Efficacy. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.123.320117
Vancouver
Hutcheson JD. From Flow to Pharmaceuticals: Single-Cell Mechanobiology and Drug Efficacy. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023. doi:10.1161/atvbaha.123.320117
BibTeX
@article{Hutcheson2023,
author = {Hutcheson, Joshua D},
title = {From Flow to Pharmaceuticals: Single-Cell Mechanobiology and Drug Efficacy},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2023},
doi = {10.1161/atvbaha.123.320117}
}
EUVIMED